Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP224986.RAZxQNxLzNvSIBpgCFloJuu8kCFOuAa2PrprzMj2c1XA0130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP224986.RAZxQNxLzNvSIBpgCFloJuu8kCFOuAa2PrprzMj2c1XA0130_provenance.
• NP850075.RABp1JWy8Lmi0LrpuJcz7nJgA5Xvdy0uT1GuOPSSwALag130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP850075.RABp1JWy8Lmi0LrpuJcz7nJgA5Xvdy0uT1GuOPSSwALag130_provenance.
• NP625424.RAjUpdR5YRs4yJKrS_-EQYlW1bfckxQF1TkTOfjQqsObM130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625424.RAjUpdR5YRs4yJKrS_-EQYlW1bfckxQF1TkTOfjQqsObM130_provenance.
• NP346960.RA120VTYYuqu6pGSusTyk_1RMGpLsUpH4SMeF142xx16s130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP346960.RA120VTYYuqu6pGSusTyk_1RMGpLsUpH4SMeF142xx16s130_provenance.
• NP630558.RAfHYkU7c60Y9xPkWrLYCMTYXWRr_LUsG2CBzOd1s61dk130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630558.RAfHYkU7c60Y9xPkWrLYCMTYXWRr_LUsG2CBzOd1s61dk130_provenance.
• NP683120.RAZVH6M9xovFJ3eTjf5HOXfeoeCrCN5BTIUNA55wD1-9k130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP683120.RAZVH6M9xovFJ3eTjf5HOXfeoeCrCN5BTIUNA55wD1-9k130_provenance.
• NP777781.RAbNCvJouO55lH9cUSP54HScaacjpW02OqwrPWJa4Albo130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP777781.RAbNCvJouO55lH9cUSP54HScaacjpW02OqwrPWJa4Albo130_provenance.
• NP535088.RAF0h5oFhPfXA5reStvBvLARdyi8OTYKPL8Mf77pEZ17Y130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP535088.RAF0h5oFhPfXA5reStvBvLARdyi8OTYKPL8Mf77pEZ17Y130_provenance.
• NP1038026.RASkWotNbNku4O33J8OOs-mXALTyNOGuKvjySuJjr1oJg130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1038026.RASkWotNbNku4O33J8OOs-mXALTyNOGuKvjySuJjr1oJg130_provenance.
• NP1038028.RAc9ce_ZdQQguCn3Xt_kQ8uDYAtmB4ib94ZHuQpUD3br0130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1038028.RAc9ce_ZdQQguCn3Xt_kQ8uDYAtmB4ib94ZHuQpUD3br0130_provenance.
• NP1038031.RARhJuyL8JA8840oib2OAUidkUhP11C6iNDqGs-DYPJc8130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1038031.RARhJuyL8JA8840oib2OAUidkUhP11C6iNDqGs-DYPJc8130_provenance.
• NP1038030.RADSii26HPk0MtFfKMYw49egGzmNGrW4JapEjg3hzBdbE130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1038030.RADSii26HPk0MtFfKMYw49egGzmNGrW4JapEjg3hzBdbE130_provenance.
• NP1038032.RAAgP-o8KYfre5X4VHQQpmgfHjp66mfAlllbivu3wRRuE130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1038032.RAAgP-o8KYfre5X4VHQQpmgfHjp66mfAlllbivu3wRRuE130_provenance.
• NP326784.RAuwp6vM_HttRvStAYpYS59sH_kS2hRRzSC--f3xRchJM130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP326784.RAuwp6vM_HttRvStAYpYS59sH_kS2hRRzSC--f3xRchJM130_provenance.
• NP644497.RAoamGOhTxuCZ5NyYSVhP41L0wwWW4C9im-3-BykqWdIo130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644497.RAoamGOhTxuCZ5NyYSVhP41L0wwWW4C9im-3-BykqWdIo130_provenance.
• NP822766.RAmg_2-r9TAotpIceXn5UcgfZnakPYT7EZBaSRo8bxBrY130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP822766.RAmg_2-r9TAotpIceXn5UcgfZnakPYT7EZBaSRo8bxBrY130_provenance.
• NP879918.RAjJSw9OdxyWXavLpRDtlQGEVa0yMhyZx1vh5O7giwH44130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879918.RAjJSw9OdxyWXavLpRDtlQGEVa0yMhyZx1vh5O7giwH44130_provenance.
• NP881683.RAlFa4LtzS9JiHyknDQ9p7hmFro9M_dI-CNcs9KKDjm0s130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881683.RAlFa4LtzS9JiHyknDQ9p7hmFro9M_dI-CNcs9KKDjm0s130_provenance.
• NP1038027.RAuOwg8glnXbTWBL6S08GNNS47O3WqM8pcOeQpfi0lecQ130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1038027.RAuOwg8glnXbTWBL6S08GNNS47O3WqM8pcOeQpfi0lecQ130_provenance.
• NP1038033.RAlp_5sqBZEU6MAZyN5GZJst6y8yDKc2neMqf5mwHUObE130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1038033.RAlp_5sqBZEU6MAZyN5GZJst6y8yDKc2neMqf5mwHUObE130_provenance.
• NP329215.RAHFCVNsEH_LDh1CNchgIO6Mo32ISt7Q5x9X1ugox9wYY130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329215.RAHFCVNsEH_LDh1CNchgIO6Mo32ISt7Q5x9X1ugox9wYY130_provenance.
• NP805798.RAKjfH2rwU_iDM2__-TRyo2l1_sDDQfDel358ceiK41TQ130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP805798.RAKjfH2rwU_iDM2__-TRyo2l1_sDDQfDel358ceiK41TQ130_provenance.
• NP786929.RALho-xP92SOqSCYZFf6mg4oATP7tTxX04virVOMC1FKo130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP786929.RALho-xP92SOqSCYZFf6mg4oATP7tTxX04virVOMC1FKo130_provenance.
• NP1038025.RAO_m5wbpv-5SND0s0QqgbvYJkb6FXM6OznY1N5chpYeI130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1038025.RAO_m5wbpv-5SND0s0QqgbvYJkb6FXM6OznY1N5chpYeI130_provenance.
• NP848360.RA6TtXHAD6yhn7dU-Rvh2SkwqFtMegI7A1zv7q0pDuXYE130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848360.RA6TtXHAD6yhn7dU-Rvh2SkwqFtMegI7A1zv7q0pDuXYE130_provenance.
• NP1038029.RA2llMByuJGkyksD2V9hD8_R14xBgy-XpVKnBMygBnvIQ130_assertion description "[Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1038029.RA2llMByuJGkyksD2V9hD8_R14xBgy-XpVKnBMygBnvIQ130_provenance.